Skye Bioscience, Inc. (SKYE)
NASDAQ: SKYE · Real-Time Price · USD
4.610
+0.440 (10.55%)
At close: Jul 3, 2025, 1:00 PM
4.590
-0.020 (-0.43%)
After-hours: Jul 3, 2025, 4:56 PM EDT
Skye Bioscience Market Cap
Skye Bioscience has a market cap or net worth of $142.84 million as of July 3, 2025. Its market cap has decreased by -53.14% in one year.
Market Cap
142.84M
Enterprise Value
84.03M
1-Year Change
-53.14%
Ranking
Category
Stock Price
$4.61
Market Cap Chart
Since April 11, 2024, Skye Bioscience's market cap has decreased from $356.10M to $142.84M, a decrease of -59.89%. That is a compound annual growth rate of -52.49%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 3, 2025 | 142.80M | 66.24% |
| Dec 31, 2024 | 85.90M | -75.88% |
View and export this data all the way back to 2024.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 699.88B |
| Johnson & Johnson | 375.78B |
| AbbVie | 335.32B |
| Novo Nordisk | 309.43B |
| UnitedHealth Group | 280.65B |
| Novartis AG | 243.28B |
| Abbott Laboratories | 233.45B |
| AstraZeneca | 219.33B |